Morales, Maria LSendra, CarmenRomero-Gomez, Manuel2023-01-252023-01-252017Morales MR, Sendra C, Romero-Gomez M. Hepatitis B and NAFLD: Lives Crossed. Ann Hepatol. 2017 March-April;16(2):185-187.1665-2681http://hdl.handle.net/10668/10900Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/HBeAgHBsAgHepatitis BNAFLDNASHHepatitis BHepatitis B Surface AntigensHepatitis B virusHepatitis B, ChronicHumansNon-alcoholic Fatty Liver Diseaseresearch article28233740open accessHepatitis BEnfermedad del hígado graso no alcohólicoFibrosisNeoplasias HepáticasResistencia a la insulinaAntígenos de superficie de la hepatitis B10.5604/16652681.1231556https://doi.org/10.5604/16652681.1231556